Less Ads, More Data, More Tools Register for FREE

Pin to quick picksXaar Regulatory News (XAR)

Share Price Information for Xaar (XAR)

Share Price is delayed by 15 minutes
Get Live Data
145.00    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 4.00 (2.847%)
Market Cap: £113.79m
XAR Live PriceLast checked at - London Stock Exchange

Intraday Xaar Share Chart

Trading Statement

20 Nov 2017 07:00

RNS Number : 9048W
Xaar PLC
20 November 2017
 

Xaar plc

 

Trading Update

 

Xaar plc ("Xaar"), a world leader in industrial inkjet technology, provides a trading update today.

 

Further to our interim results statement in September and our earlier trading update in July, in which we indicated that growth in revenues from new products was expected to be second half weighted, the board now expects that revenue in the second half year will be broadly in line with the first half. The shortfall against previous expectations results largely from fewer than planned new printer installs of Xaar's 2001 Printhead, and slower than anticipated ramp up of the Xaar 1201 Printhead due to supply constraints.

In ceramics, the printhead replacement business is now anticipated to represent c.70% of revenues in 2017. The new 1003 Printhead has performed strongly in this market but as competition for new printer installs continues to intensify, we have seen more limited success with the 2001 product.

Demand for the 1201 Printhead remains strong, but due to supply constraints, we have not been able to fulfil all of the demand this year. We expect supply will improve with new capacity coming on stream next year, and we continue to expect significant growth in 2018.

Although disappointed by the revenue shortfall on the underlying business, we are encouraged by our reducing dependence on our legacy ceramics business, where there is little visibility, and increasing competitive pressure. Our 2020 vision and commitment to delivering growth from new products in new markets is undiminished but the timing of ramp up of the range of new products we have introduced remains less predictable. In 2017 we expect that 80% of our underlying revenues will be from the seven new products introduced and new businesses acquired in the last two years. This progress, together with our previously announced increased investment in sales and marketing, supports our continuing transformation to a more diversified and customer-centric company.

 

Enquiries:

 

Xaar plc

 

Doug Edwards, Chief Executive Officer

Lily Liu, Chief Financial Officer

 

+44 (0)1223 423 663 

Tulchan Communications

James Macey White

David Ison

Deborah Roney

+44 (0)20 7353 4200

 

About Xaar

Xaar is a world-leader in the development of inkjet technology and manufacture of piezoelectric drop-on-demand industrial printheads. The company also develops and sells ink systems, electronics and fluid optimisation services to accelerate inkjet system development and adoption. Xaar printheads incorporate patented technology, which delivers unbeatable performance when decorating, patterning, depositing functional coatings on, or adding structure to, a variety of industrial and consumer products. Today leading manufacturers worldwide, in sectors ranging from ceramics, wide-format graphics and labels to direct-to-shape packaging and decorative laminates, choose Xaar's printheads because they are extremely precise, exceptionally versatile, incredibly reliable, and designed for high-volume production. Additional information about Xaar is available at www.xaar.com

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTVKLFFDFFZFBF
Date   Source Headline
1st May 20192:21 pmRNSTotal Voting Rights
1st May 201910:15 amRNSGrant of Options
30th Apr 20192:59 pmRNSHolding(s) in Company
2nd Apr 201910:31 amRNSTotal Voting Rights
21st Mar 20197:00 amRNSXaar plc 2018 Full Year Results
11th Mar 20197:00 amRNSTrading Update
1st Mar 20199:53 amRNSTotal Voting Rights
1st Feb 20191:12 pmRNSTotal Voting Rights
2nd Jan 20194:48 pmRNSBlock Listing Six Monthly Return
2nd Jan 20194:45 pmRNSTotal Voting Rights
2nd Jan 201912:07 pmRNSSecond Price Monitoring Extn
2nd Jan 201912:02 pmRNSPrice Monitoring Extension
28th Dec 20187:00 amRNSTrading Update
3rd Dec 20184:12 pmRNSTotal Voting Rights
20th Nov 20187:00 amRNSNEOS AND KELENN TECHNOLOGY ADOPT XAAR 5601
5th Nov 201811:12 amRNSHolding(s) in Company
1st Nov 20183:21 pmRNSTotal Voting Rights
24th Oct 20187:00 amRNSAppointment of CFO and Company Secretary
11th Oct 201812:07 pmRNSSecond Price Monitoring Extn
11th Oct 201812:02 pmRNSPrice Monitoring Extension
10th Oct 201812:07 pmRNSSecond Price Monitoring Extn
10th Oct 201812:02 pmRNSPrice Monitoring Extension
1st Oct 20185:20 pmRNSTotal Voting Rights
5th Sep 20187:00 amRNSW&H Chooses Xaar 5601
5th Sep 20187:00 amRNSXaar 2018 Interim Results
4th Sep 20188:30 amRNSTotal Voting Rights
4th Sep 20188:05 amRNSHolding(s) in Company
30th Aug 20187:00 amRNSTrading Update
1st Aug 20182:40 pmRNSTotal Voting Rights
12th Jul 20187:00 amRNSAnnouncement of 3D Printing Joint Investment
2nd Jul 20185:39 pmRNSBlock listing Interim Review
2nd Jul 20185:37 pmRNSTotal Voting Rights
27th Jun 20187:00 amRNSTrading Statement
1st Jun 20182:25 pmRNSTotal Voting Rights
30th May 20187:00 amRNSBoard Change
22nd May 201812:12 pmRNSResult of AGM
1st May 20185:02 pmRNSTotal Voting Rights
11th Apr 201812:02 pmRNSPrice Monitoring Extension
5th Apr 20189:38 amRNSGrant of Options
3rd Apr 201812:26 pmRNSTotal Voting Rights
3rd Apr 201810:54 amRNSBoard Change
23rd Mar 20182:10 pmRNSHolding(s) in Company
21st Mar 20187:00 amRNSXaar plc 2017 Full Year Results
20th Mar 20181:25 pmRNSHolding(s) in Company
12th Mar 201810:58 amRNSHolding(s) in Company
1st Mar 20183:57 pmRNSTotal Voting Rights
2nd Feb 20188:00 amRNSNotice of Scheduled Results
1st Feb 201811:11 amRNSTotal Voting Rights
5th Jan 20187:00 amRNSBlock listing Interim Review
5th Jan 20187:00 amRNSIssue of Equity - Share Scheme and Block Listing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.